Citation Impact
Citing Papers
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
Inhibition of NADPH oxidase promotes alternative and anti‐inflammatory microglial activation during neuroinflammation
2011
Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain
2004
Elevated agonist binding to α2-adrenoceptors in the locus coeruleus in major depression
2003
Depression
2018 Standout
Antidepressants increase neural progenitor cells in the human hippocampus
2009
The Human Brain Revisited Opportunities and Challenges in Postmortem Studies of Psychiatric Disorders
2002
Cerebellar synaptic protein expression in schizophrenia
2001
RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia
2010 StandoutNobel
Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis
2003
The neuropathology of schizophrenia
1999
Memantine in Moderate-to-Severe Alzheimer's Disease
2003 Standout
The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications
2004
Quantification of Alzheimer pathology in ageing and dementia: age‐related accumulation of amyloid‐β(42) peptide in vascular dementia
2006
Estimated Neuronal Populations and Volumes of the Hippocampus and Its Subfields in Schizophrenia
2002
Sjögren's syndrome
2005 Standout
Specific Hippocampal Volume Reductions in Individuals at Risk for Alzheimer’s Disease
1997
Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood
2007
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
2002 Standout
Delirium in elderly people
2013 Standout
Copper, iron and zinc in Alzheimer's disease senile plaques
1998 Standout
Alzheimer's disease
2011 Standout
Classification and basic pathology of Alzheimer disease
2009
The Cholinergic Hypothesis of Age and Alzheimer’s Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development
2003
Novel Functions of Cholinesterases in Development, Physiology and Disease
1994
Mild Cognitive Impairment
2011 Standout
Pre‐and Postmortem Influences on Brain RNA
1993
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
2000 Standout
Topography of brain atrophy during normal aging and alzheimer's disease
1996
Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease
1989
Neuroimaging Findings in Twins Discordant for Alzheimer’s Disease
1998
Cell division in the CNS: Protective response or lethal event in post-mitotic neurons?
2006
Monetary Costs of Dementia in the United States
2013 Standout
The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology
2003
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Identifying severely atrophic cortical subregions in Alzheimer's disease
2003
Neuroplasticity Failure in Alzheimer's Disease
1999
White Matter Changes in Schizophrenia
2003
Alzheimer disease therapy—moving from amyloid-β to tau
2013
A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia
2003
Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
1997
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Diabetic Retinopathy
2012 Standout
Diagnosis of Alzheimer's Disease
1997
Genetics of human prefrontal function
2003
Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons
2004
T1ρ MRI in Alzheimer's Disease: Detection of Pathological Changes in Medial Temporal Lobe
2010
Neocortical excitation/inhibition balance in information processing and social dysfunction
2011 StandoutNature
Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs
2000
Neuropathology of Cognitively Normal Elderly
2003
Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly
2001
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease
2002
Differential synaptic changes in the striatum of subjects with undifferentiated versus paranoid schizophrenia
2008
Alzheimer's disease
2006 Standout
Dementia with Lewy Bodies. A Distinct Non‐Alzheimer Dementia Syndrome?
1998
Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer Disease
1998 Standout
Functional organization of the hippocampal longitudinal axis
2014 StandoutNobel
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
Imaging Physiologic Dysfunction of Individual Hippocampal Subregions in Humans and Genetically Modified Mice
2000 StandoutNobel
Alzheimer's Disease
2010 Standout
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
2003 Standout
Major Depressive Disorder
2008 Standout
Capturing side-effect of medication to identify persons at risk of delirium
2010
M1 Agonists for the Treatment of Alzheimer's Disease.
1996
Model‐guided microarray implicates the retromer complex in Alzheimer's disease
2005
Whole Brain Segmentation
2002 Standout
Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia
2001
Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease
1994
Human Hippocampal Neurogenesis Persists throughout Aging
2018
Characterization of the Interaction of a Recombinant Soluble Neuroligin-1 with Neurexin-1β
2003 StandoutNobel
Alzheimer's Disease
2004 Standout
Oxidative stress: Free radical production in neural degeneration
1994
Hippocampal tin, aluminum and zinc in Alzheimer's disease
1993
Amyloid β-peptide is produced by cultured cells during normal metabolism
1992 StandoutNature
Measurement of Phosphorylated Tau Epitopes in the Differential Diagnosisof Alzheimer Disease
2004
Postmortem Delay Has Minimal Effect on Brain RNA Integrity
2007
The neuropathology of primary mood disorder
2002
The molecular neurobiology of depression
2008 StandoutNature
No increased incidence of Alzheimer's disease in elderly schizophrenics
1999
Diabetes downregulates presynaptic proteins and reduces basal synapsin I phosphorylation in rat retina
2008
Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions
2004
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease
1997
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Three-Dimensional Structure of the Complexin/SNARE Complex
2002 StandoutNobel
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
2006 Standout
Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion
2002
Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia
1997
Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samples
2006
Silicate complexes of aluminum(III) in aqueous systems
2001
APOLIPOPROTEIN E ALLELES AS RISK FACTORS IN ALZHEIMER'S DISEASE
1996
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 StandoutScience
Copper Active Sites in Biology
2014 Standout
α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies
1998 Standout
Transcriptional neoteny in the human brain
2009 StandoutNobel
Dynamics of Gray Matter Loss in Alzheimer's Disease
2003
Aβ Deposition Is Associated with Neuropil Changes, but not with Overt Neuronal Loss in the Human Amyloid Precursor Protein V717F (PDAPP) Transgenic Mouse
1997
Measuring the thickness of the human cerebral cortex from magnetic resonance images
2000 Standout
Linear measures of atrophy in mild Alzheimer disease.
1996
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.
1996
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
1996
Aluminum: A Neurotoxic Product of Acid Rain
1994
The Hydrothermal Synthesis of Zeolites: History and Development from the Earliest Days to the Present Time
2003 Standout
Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI
2004 Standout
Electrochemiluminescence (ECL)
2004 Standout
Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis
2003
Microanalysis of Senile Plaques Using Nuclear Microscopy
1993
Bioinorganic Chemistry of Alzheimer’s Disease
2012
Neuroleptic drugs in dementia: benefits and harm
2006
Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function
2005 StandoutScience
Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation
2004 StandoutNobel
Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia
2003
MRI of the human brain at 130 microtesla
2013 StandoutNobel
Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease
1999
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD
2000
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Amyloid precursor protein (APP) traffics from the cell surface via endosomes for amyloid β (Aβ) production in the trans -Golgi network
2012 StandoutNobel
Protection from Oxidative Stress–Induced Apoptosis in Cortical Neuronal Cultures by Iron Chelators Is Associated with Enhanced DNA Binding of Hypoxia-Inducible Factor-1 and ATF-1/CREB and Increased Expression of Glycolytic Enzymes, p21waf1/cip1, and Erythropoietin
1999 StandoutNobel
Rapid metabolic evolution in human prefrontal cortex
2011 StandoutNobel
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
2007 StandoutScience
Muscarinic Receptor Agonists in Alzheimer??s Disease
1999
Dynamic mapping of human cortical development during childhood through early adulthood
2004 Standout
Relationship Between ApoE, MRI Findings, and Cognitive Function in the Cardiovascular Health Study
1998
Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme
1996
Hippocampal atrophy in Alzheimer disease: Age matters
2006
Plaque-induced neurite abnormalities: Implications for disruption of neural networks in Alzheimer’s disease
1999
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease
2001
Works of B. McDonald being referenced
Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography
1992
Synaptophysin gene expression in human brain: A quantitative in situ hybridization and immunocytochemical study
1994
Anomalies of cerebral asymmetry in schizophrenia interact with gender and age of onset: a post-mortem study
1998
Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer's disease
1991
Temporal-lobe length is reduced, and gyral folding is increased in schizophrenia: a post-mortem study
1998
Accuracy of Clinical Operational Diagnostic Criteria for Alzheimer’s Disease in Relation to Different Pathological Diagnostic Protocols
1998
Absence of aluminium in neuritic plaque cores in Alzheimer's disease
1992 Nature
The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins
1995
Characterisation of Human 5‐Hydroxytryptamine2A and 5‐Hydroxytryptamine2C Receptors Expressed in the Human Neuroblastoma Cell Line SH‐SY5Y: Comparative Stimulation by Hallucinogenic Drugs
1996
Size of hippocampal pyramidal neurons in schizophrenia
2003
Alzheimer's disease: specific increases in a G protein subunit (GSα) mRNA in hippocampal and cortical neurons
1991
Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer’s disease prospectively assessed for behavioural changes
2000
Increased muscarinic receptor messenger RNA in Alzheimer's disease temporal cortex demonstrated by in situ hybridization histochemistry
1991
Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease
1994
Relative Roles of Plaques and Tangles in the Dementia of Alzheimer's Disease: Correlations Using Three Sets of Neuropathological Criteria
1995
Comparison of Pathological Diagnostic Criteria for Alzheimer Disease
1998
The preliminary characterisation of a protein present in cerebrospinal fluid and serum using a monoclonal antibody which reacts immunohistochemically with amyloid deposits in Alzheimer brains.
1989
Cholinergic deficits contribute to behavioral disturbance in patients with dementia
2000
Increased tau messenger RNA in Alzheimer's disease hippocampus.
1990
Prospective study of relations between cortical Lewy bodies, poor eyesight, and hallucinations in Alzheimer's disease.
1995
Identification and analysis of senile plaques using nuclear microscopy
1991